Pfizer has also partnered with TrumpRx, a website launched by the US federal government, where people will be able to buy prescription drugs at discounted rates negotiated by the government. Pfizer will sell some of its products at a 50% average discount on the direct-to-consumer website.
This mandate is part of Trump’s push to have US drugmakers companies adopt the “most favoured nation” pricing policy on their prescription drugs. This policy involves US residents paying for a prescription drug at an amount that is comparable to what is paid in the developing countries.
The Trump administration has argued that people within the US pay “massively higher prices” for the same drug compared to other countries. It said that the US was “subsidizing prices” for the rest of the world with its high cost for prescription medication, and that this would be discontinued.
The President had also stated in August that he will reduce drug prices by 1,400% to 1,500%.
